Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. - Wikidata - awgldk - TriplyDB

Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.

Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.

http://www.wikidata.org/entity/Q45017329

about

Clonal origin and spread of metastatic prostate cancer The mutational landscape of prostate cancer Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer Structural variation discovery in the cancer genome using next generation sequencing: computational solutions and perspectives International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors Abnormal dosage of ultraconserved elements is highly disfavored in healthy cells but not cancer cells Gene Expression Differences in Prostate Cancers between Young and Old Men Findings made in gene panel to whole genome sequencing: data, knowledge, ethics - and consequences?Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response element Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer.Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness.Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment Systematic identification and characterization of RNA editing in prostate tumors.Molecular pathways and targets in prostate cancer Impact of soy isoflavones on the epigenome in cancer prevention.PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis FISH Oracle 2: a web server for integrative visualization of genomic data in cancer research.Role of non-coding sequence variants in cancer.Current state of the art, multimodality research and future visions for the treatment of patients with prostate cancer: consensus results from "Challenges and Chances in Prostate Cancer Research Meeting 2013".Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking.Genomic rearrangements in prostate cancer.Constitutive activity of the androgen receptor.Crosstalking between androgen and PI3K/AKT signaling pathways in prostate cancer cells.Comparative genomic and transcriptomic analyses of LNCaP and C4-2B prostate cancer cell lines.Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells.Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer.The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients.Defining order and timing of mutations during cancer progression: the TO-DAG probabilistic graphical model Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis.Tissue-specific tumorigenesis: context matters.Predictive Modeling of Drug Treatment in the Area of Personalized Medicine.Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrol A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men.LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations Translational and clinical implications of the genetic landscape of prostate cancer.

P2860

Q26752873-924089DB-C41F-47AE-AC0A-BC050E1782B2 Q26851631-433D4011-02A4-45B0-9F2B-4A39A5A68F2C Q26858922-9518B73B-FCC1-4E80-8C25-98BC2CDD740C Q26991436-2DFF0538-7046-4949-A143-B15906425380 Q28257710-E3BCCFFE-BEA4-4E80-90CF-C1151D328997 Q28396411-07C359EF-8E85-4CE1-AC92-46E8B7E4925A Q28468529-697CE8E3-7DF9-4FAF-9CF1-2DE5B00EBC4B Q31114379-A59C57CE-5DCF-4C33-AA66-11B9F8C3D0F9 Q33640983-9DB6C48F-75FD-4536-B321-F3365E869955 Q33663401-9ECC88A8-B61F-4842-9899-124CC6CB8D6F Q33761801-1CACAFE4-B7FD-473C-ADEB-FF5BEAE77848 Q33850638-907A1BD7-C387-4D7B-9297-44DC7D8E60E8 Q33852664-7C38958C-DEF9-4CB8-8A7E-189B57CA68E5 Q33921151-7DDF3F82-1FBF-484E-B36A-E342FFAECFFF Q34365632-C66E35FE-4CDF-4CB0-8FB5-2B079ADB6448 Q34411665-273A2E6F-8A91-4E71-A5DB-354A4BDDC867 Q34434937-152984FF-5AC1-43CB-8892-CEBBFC933323 Q34504704-0AC625A8-47C6-454C-9F16-1485162AAA87 Q34509633-25CFD863-A9CE-4533-B5F2-2B484A89E2B7 Q34528219-A72A28BF-6159-4091-9CEE-563671286596 Q34545220-2D5BD3A3-19A9-4FD3-BFAA-374AE924D6E6 Q34722101-A34C6053-3CA7-4431-895C-5D7084DDEA75 Q34775572-C56F3A00-A191-4480-AB50-C4099AF1E087 Q35048965-18F2D1E0-74CE-4A85-8436-5F3B073CE2E4 Q35108540-6D7C91F1-BF3C-49C2-9230-66F2C708FC03 Q35168191-1B945D2A-B9D8-48BF-909A-1855BD0648A3 Q35235374-E16EE58D-B011-4A7B-88E5-52450DED0E91 Q35407284-77C2F50B-4BE8-4817-A3D3-888F798D61A4 Q35706611-7538FDE7-D2A5-4BC4-9C67-922D5ABD1BFA Q35731092-6D6745A5-F4FD-4C99-A105-1EC18D50A54C Q35828702-A552C3D8-2BC2-439E-AE4C-A6624B8F1CCB Q36105102-FB362770-C4AA-4B97-B40F-C3C372B228DB Q36149716-052BF261-9F69-4F5B-A223-33A30CD24DA4 Q36189798-8055F401-C79D-45DB-A943-93425F637E5A Q36296335-0D3A7C49-FE5C-48C7-B1A4-49C9DF0A5D92 Q36351777-C448B0EF-EC45-4511-9FF3-DF40C4E29A7C Q36361936-61A73226-F14C-41F3-9AC6-41CBB9A503C2 Q36437601-9F175CDB-6AD7-4FDF-8D7B-F4844720118B Q36676636-C8F95530-32F3-42B6-B09E-E67A98B69666 Q37270512-ECEA777D-6CCD-422E-9073-4D4E8ACBF121

P2860

Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.

http://www.wikidata.org/entity/Q45017329

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Integrative genomic analyses r ...... n early-onset prostate cancer.

@en

Integrative genomic analyses r ...... n early-onset prostate cancer.

@nl

type

label

Integrative genomic analyses r ...... n early-onset prostate cancer.

@en

Integrative genomic analyses r ...... n early-onset prostate cancer.

@nl

prefLabel

Integrative genomic analyses r ...... n early-onset prostate cancer.

@en

Integrative genomic analyses r ...... n early-onset prostate cancer.

@nl

P1433

Q45017329-39B64BA3-E348-4C0E-9881-498F31D434AF

P1476

Q45017329-754279BC-5F50-4549-9E78-83C5F5E0F37A

P2093

Q45017329-0829D906-5DA0-4802-A6EB-0772FE431284

Q45017329-0DDC637B-7AF1-4693-8CDC-1736AB051CF5

Q45017329-13C6343C-EECF-4A3E-86E3-0F50386F6CDB

Q45017329-1416C39E-28C6-4556-8B8C-2DD88E4777B5

Q45017329-1641D671-5F01-4C85-8675-9815DC53FBB3

Q45017329-1BF6CA01-35A0-4C58-9E3C-844D8B0A1AF4

Q45017329-1C85BEF0-C4F6-416D-9FA6-B1EF42F69C1C

Q45017329-1D5F8D26-2EF0-4509-8422-AC0D8B57B9CA

Q45017329-1EB51A84-12DF-4932-9022-B248A4ED1FD5

Q45017329-1F852955-8F4E-4B01-9DA6-E9868FBB7DF3

P304

Q45017329-DBF9D629-5C3E-45FC-ACDA-2C967FFC4BF9

P31

Q45017329-05462C1F-3236-437D-BDC9-8F7D58E680BD

P356

Q45017329-D2DA2E38-CAE0-4C3A-BEF2-3F6E31CC78D7

P433

Q45017329-ACEFD428-5E50-4787-B9D3-7C94D3B8E74F

P478

Q45017329-98E4A477-52B6-412E-859C-539D92A1890A

P50

Q45017329-08A659CE-3A60-47E2-95AC-93D51E876765

Q45017329-0A33ACAE-8E41-4796-A046-CF9BD024030D

Q45017329-0EF0290D-C00A-4394-9539-2F23FBB74989

Q45017329-3D53149C-D585-4FFB-B570-2D5B921B199B

Q45017329-54264B9B-BA54-4E4C-B9AC-4AB65CEA1F11

Q45017329-5E79054C-E257-4087-AF94-DF457125A7F8

Q45017329-6175FC28-3307-4E17-B238-C3B4FE23287C

Q45017329-6861B64F-4FB7-4D5C-B8FC-77512061ECFE

Q45017329-868E40C1-DFE4-4AD4-9AD2-BA650AAF7579

Q45017329-8F23ECF5-F8F1-4A42-B950-0D208168A6E9

P577

Q45017329-8623BE46-A3D2-4365-981B-5633707B43C6

P5875

Q45017329-8DDF4328-ECF5-435B-9B90-B60E25DCD984

P698

Q45017329-284853D7-25F6-4ADE-A2F2-0FA1888DF644

P356

J.CCR.2013.01.002

P1433

P1476

Integrative genomic analyses r ...... n early-onset prostate cancer.

@en

P2093

Adrian M Stütz

http://www.w3.org/2001/XMLSchema#string

Antje Krohn

http://www.w3.org/2001/XMLSchema#string

Christian Lawerenz

http://www.w3.org/2001/XMLSchema#string

Christoph Plass

http://www.w3.org/2001/XMLSchema#string

Constance Baer

http://www.w3.org/2001/XMLSchema#string

Cynthia C Bartholomae

http://www.w3.org/2001/XMLSchema#string

Daniela Wuttig

http://www.w3.org/2001/XMLSchema#string

Dieter Weichenhan

http://www.w3.org/2001/XMLSchema#string

Dmitri Parkhomchuk

http://www.w3.org/2001/XMLSchema#string

Guido Sauter

http://www.w3.org/2001/XMLSchema#string

P304

159-170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2013.01.002

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Christof von Kalle

Marie-Laure Yaspo

Hans-Jörg Warnatz

Joachim Weischenfeldt

Holger Sültmann

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235628229

http://www.w3.org/2001/XMLSchema#string

P698

23410972

http://www.w3.org/2001/XMLSchema#string